Parham Sadeghipour, MD; Yaser Jenab, MD; Jamal Moosavi, MD; et al.
free access
JAMA Cardiol. 2022;7(12):1189-1197. doi:10.1001/jamacardio.2022.3591
This randomized clinical trial investigates the effects of conventional catheter-directed thrombolysis plus anticoagulation in patients with acute intermediate-high risk of pulmonary embolism.
Siddharth M. Patel, MD; Arman Qamar, MD, MPH; Robert P. Giugliano, MD, SM; et al.
free access
JAMA Cardiol. 2022;7(12):1199-1206. doi:10.1001/jamacardio.2022.3627
This secondary analysis of a randomized clinical trial evaluates the association of serial changes in high-sensitivity troponin T (hsTnT) and risk of cardiovascular events in stable patients with prior acute coronary syndrome (ACS).
Utibe R. Essien, MD, MPH; Karen Chiswell, PhD; Lisa A. Kaltenbach, MS; et al.
free access
JAMA Cardiol. 2022;7(12):1207-1217. doi:10.1001/jamacardio.2022.3704
This cohort study compares oral anticoagulation use at discharge and atrial fibrillation鈥搑elated outcomes by race and ethnicity in the Get With The Guidelines鈥揂trial Fibrillation registry.
Eric J. Brandt, MD, MHS; Tammy Chang, MD, MPH, MS; Cindy Leung, ScD, MPH; et al.
free access
JAMA Cardiol. 2022;7(12):1218-1226. doi:10.1001/jamacardio.2022.3729
This cross-sectional study examines data from the National Health and Nutrition Examination Survey to assess the prevalence of food insecurity among individuals with cardiovascular disease or cardiometabolic risk factors and analyze any differences across racial and ethnic groups.
Akshay S. Desai, MD, MPH; Pardeep S. Jhund, MBCHB, PhD; Brian L. Claggett, PhD; et al.
open access
JAMA Cardiol. 2022;7(12):1227-1234. doi:10.1001/jamacardio.2022.3736
This pooled analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) and Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) trials investigates the effect of dapagliflozin on specific causes of cardiovascular mortality across the spectrum of ejection fraction.
Emily C. O鈥橞rien, PhD; Hillary Mulder, MS; W. Schuyler Jones, MD; et al.
free access
JAMA Cardiol. 2022;7(12):1235-1243. doi:10.1001/jamacardio.2022.3844
This concordance substudy of a comparative effectiveness research trial investigates concordance between patient-reported health data and electronic health data among patients with atherosclerotic cardiovascular disease.
Michel Azizi, MD, PhD; Felix Mahfoud, MD, MA; Michael A. Weber, MD; et al.
open access
JAMA Cardiol. 2022;7(12):1244-1252. doi:10.1001/jamacardio.2022.3904
This prespecified analysis of the Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN TRIO) randomized clinical trial investigates if the blood pressure鈥搇owering effect of ultrasound renal denervation in patients with resistant hypertension is maintained after the addition of antihypertensive medication through 6 months.